Cleared Traditional

K820435 - BAXA ADDISEAL

K820435 is an FDA 510(k) clearance for BAXA ADDISEAL, manufactured by Baxa Corp., Sub. of Cook Group, Inc.. The device is a Class 2 General Hospital device with product code KPE cleared through the Traditional 510(k) pathway after a 19-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 1982
Decision
19d
Days
Class 2
Risk

K820435 is an FDA 510(k) clearance for the BAXA ADDISEAL. Classified as Container, I.v. (product code KPE), Class II - Special Controls.

Submitted by Baxa Corp., Sub. of Cook Group, Inc. (Mchenry, US). The FDA issued a Cleared decision on March 8, 1982 after a review of 19 days - a notably fast clearance cycle.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5025 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

FDA 510(k) Submission Details - K820435

510(k) Number K820435 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 17, 1982
Decision Date March 08, 1982
Days to Decision 19 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
110d faster than avg
Panel avg: 129d · This submission: 19d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

KPE Device Classification - Class 2, Special Controls

Product Code KPE Container, I.v.
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5025
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - KPE Container, I.v.

All 116
Devices cleared under the same product code (KPE) and FDA review panel - the closest regulatory comparables to K820435.
DECANTER MODELS-VARIOUS
K830232 · Steri-Sytems, Corp. · Feb 1983
POUR BOTTLE DECANTER #2010
K823538 · Medi-Plant Intl. · Jan 1983
IV ALERT SYSTEM
K820200 · Allied Medical Technologies, Inc. · Mar 1982
BAXA ADLI SEAL
K813435 · Baxa Corp., Sub. of Cook Group, Inc. · Dec 1981
SET FOR ASEPTIC DECANTING OF A FLEX I.V
K812852 · Dip, Inc. · Nov 1981
IVA SEAL II
K812527 · U.S. Clinical Products, Inc. · Sep 1981